NCT06668831View on ClinicalTrials.gov

Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

October 12, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 30, 2025

Conditions

Hemodialysis

Trial Locations (1)

CH-6903

RECRUITING

Servizio di Nefrologia, Ospedale Regionale di Lugano, Civico, Lugano

All Listed Sponsors

lead

Antonio Bellasi

OTHER